Thoracic Cancer

Papers
(The H4-Index of Thoracic Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Issue Information300
Issue Information48
Issue Information46
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 144
Issue Information42
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer40
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway33
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring 33
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction31
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma30
Issue Information29
Pathological characteristics of lung tumors in Sri Lanka 2017–202127
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report27
Sortilin‐1, Targeted by miR‐146a, Regulates the Behavior of Non‐Small Cell Lung Cancer26
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China26
PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC25
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study25
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report25
Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS23
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report23
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 203523
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab23
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomize23
0.11145496368408